Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma

Head and Neck

Volumn 31, Issue 9, 2009, Pages 1152-1163

  Clayman, Gary L ^a   Shellenberger, Thomas D ^a,b   Ginsberg, Lawrence E ^a   Edeiken, Beth S ^a   El Naggar, Adel K ^a   Sellin, Rena V ^a   Waguespack, Steven G ^a   Roberts, Dianna B ^a   Mishra, Anupam ^a   Sherman, Steven I ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b M D ANDERSON CANCER CENTER ORLANDO   (United States)

Author keywords

Approach; Central compartment; Metastatic; Papillary thyroid carcinoma; Recurrence

Indexed keywords

PARATHYROID HORMONE; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; DYSPHAGIA; FEMALE; HORNER SYNDROME; HUMAN; HYPOPARATHYROIDISM; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECURRENT LARYNGEAL NERVE PALSY; RETROSPECTIVE STUDY; SUBTOTAL THYROIDECTOMY; SURGICAL APPROACH; SURGICAL TECHNIQUE; THYROID CARCINOMA; THYROID GLAND; THYROID PAPILLARY CARCINOMA; THYROID SCINTISCANNING; THYROIDECTOMY; TRACHEOTOMY; TREATMENT OUTCOME; TREATMENT PLANNING; VOCAL CORD PARALYSIS; WOUND COMPLICATION; WOUND INFECTION;

ADOLESCENT; ADULT; CARCINOMA, PAPILLARY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; THYROID NEOPLASMS; YOUNG ADULT;

EID: 68549107977     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21079     Document Type: Article

References (8)

1. Agnes R, Gilles H, Marie-Odile B, et al. Prognostic factors associated with the survival of patients developing locoregional recurrences of differentiated thyroid carcinomas. J Clin Endocrinol Metab 2004;89:5362-5368.
2. Jemal A, Siegal R, Ward E, et al. Cancer Statistics. CA Cancer J Clin 2008;58:71-96.
3. Hundahl SA, Cady B, Cunningham MP, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. US and German Thyroid Cancer Study Group. An American College of Surgeons Commission on cancer patient care evaluation study. Cancer 2000;89:202-217.
4. Sherman SI, Angelos P, Ball DW, et al. Thyroid carcinoma. J Natl Compr Cancer Netw 2005;3:404-457.
5. Samaan NA, Schulz PN, Hickey RC, et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab 1992;75:714-720.
6. Waseem Z, Palme CE, Walfish P, Freeman JL. Prognostic implications of site of recurrence in patients with recurrent well-differentiated thyroid cancer. J Otolaryngol 2004;33:339-344. (Pubitemid 40395387)
7. Kim MK, Mandel SH, Balock A, et al. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 2004;130:1214-1216.
8. Schuff KG, Weber SM, Givi B, et al. Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer. Laryngoscope 2008;118:768-775. (Pubitemid 351631273)